Skip to main content
Log in

Cocktail controversy for cancer

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

The Italian Health Ministry recently announced that it would start clinical trials of the controversial anticancer drug cocktail developed by Professor Luigi Di Bella. The decision is a response to strong public pressure on the Italian government to reimburse the treatment following claims that it is a ‘miracle cure’. The government set up an international panel of cancer experts to advise on the trials, which were scheduled to begin last month. Dr Kate Law who is head of clinical information at the UK Cancer Research Campaign (CRC) shed more light on the subject during an interview with Inpharma .

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Higgins, G. Cocktail controversy for cancer. Inpharma Wkly. 1131, 3 (1998). https://doi.org/10.2165/00128413-199811310-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199811310-00003

Keywords

Navigation